AN2 Therapeutics, Inc.
ANTXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $162.93M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.00$7.19
- Volume (live)
- -
- Avg. volume (3M)
- 292.81K
AN2 Therapeutics (ANTX) Stock Price & Financial Analysis
AN2 Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.52 - $3.72 |
|---|---|
| 52-Week High | $7.19 |
| 52-Week Low | $1.00 |
| Open | $3.57 |
| Volume (last close) | 95.19K |
| Average Volume (3M) | 292.81K |
| 50-Day MA | $5.21 |
|---|---|
| 200-Day MA | $3.96 |
| 1-Year Change | +211.11% |
| Market Cap | 162.93M |
|---|---|
| Shares Outstanding | 44.76M |
| Price to Book (P/B) | 2.15 |
| EV/EBITDA | -3.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
AN2 Therapeutics at a Glance
As of the Oct 22, 2026 close, AN2 Therapeutics (ANTX) has a market capitalization of $162.93M.
As of its latest reported balance sheet, it holds $44.32M in cash and securities against $0.00 of debt, a net cash position of $44.32M.
AN2 Therapeutics does not currently pay a dividend.
The share price is up 211.1% over the past year. At $3.64 (the Oct 22, 2026 close) it sits within its 52-week range of $1.00 to $7.19, below its 200-day moving average of $3.96.
Frequently Asked Questions About AN2 Therapeutics
What is the current stock price for ANTX?
As of the Oct 22, 2026 close, ANTX stock trades at $3.64. The 52-week range is $1.00–$7.19, with a day range of $3.52–$3.72.
What is the P/E ratio for ANTX?
The P/E ratio (Price-to-Earnings) for ANTX is shown in the Key Statistics section. This valuation metric helps compare AN2 Therapeutics, Inc. to industry peers.
Does ANTX pay dividends?
AN2 Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANTX?
Analyst ratings and recommendations for ANTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ANTX?
As of the Oct 22, 2026 close, AN2 Therapeutics's market capitalization is $162.9M, classifying it as a micro-cap company. AN2 Therapeutics operates in the Healthcare sector within the Biotechnology industry.